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Introduction. Exhaled breath condensate (EBC) is a noninvasive method to collect samples from the respiratory tract. Usually, a
thermoelectric cooling module is required to collect suﬃcient EBC volume for analyses. In here, we assessed the feasibility of
cytokine and chemokine detection in EBC collected directly from the ventilator circuit without the use of a cooling module:
swivel-derived exhaled breath condensate (SEBC). Methods. SEBC was prospectively collected from the swivel adapter and
stored at -80°C. The objective of this study was to detect cytokines and chemokines in SEBC with a multiplex immunoassay.
Secondary outcomes were to assess the correlation between cytokine and chemokine concentrations in SEBC and mechanical
ventilation parameters, systemic inﬂammation parameters, and hemodynamic parameters. Results. Twenty-nine SEBC samples
were obtained from 13 ICU patients. IL-1β, IL-4, IL-8, and IL-17 were detected in more than 90% of SEBC samples, and
signiﬁcant correlations between multiple cytokines and chemokines were found. Several signiﬁcant correlations were found
between cytokines and chemokines in SEBC and mechanical ventilation parameters and serum lactate concentrations.
Conclusion. This pilot study showed that it is feasible to detect cytokines and chemokines in SEBC samples obtained without a
cooling module. Despite small sample size, correlations were found between cytokines and chemokines in SEBC and mechanical
ventilation parameters, as well as serum lactate concentrations. This simple SEBC collection method provides the opportunity to
collect EBC samples in large prospective ICU cohorts.
1. Introduction
Pulmonary inﬂammation is the hallmark of acute respiratory
distress syndrome (ARDS) and ventilator-associated pneu-
monia (VAP) [1, 2]. Consecutive measurements of pulmo-
nary inﬂammation could identify mechanically ventilated
patients that develop ARDS or VAP in an early phase of
the disease or even patients at risk.
Bronchoscopy with bronchoalveolar lavage is an invasive
method that is used to directly detect pulmonary inﬂamma-
tion. However, a bronchoscopy is not routinely performed
until clinical or radiological symptoms of ARDS or VAP have
developed. Exhaled breath condensate (EBC) is a noninva-
sive method to sample the airway lining ﬂuid that covers
the respiratory tract [3–5]. A variety of inﬂammatory bio-
markers has been detected in EBC [6, 7]. In mechanically
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ventilated patients, EBC samples are collected by guiding
exhaled breath air through a thermoelectric cooling module
using additional tubing. Cooling down exhaled breath air is
required to collect suﬃcient sample volume for analyses [8].
The necessity for a cooling module and additional mechani-
cal ventilation tubing prevented the collection of EBC in large
prospective cohorts at the intensive care unit (ICU), as it is
both complex and time-consuming.
Multiplex immunoassays are able to detect cytokines and
chemokines in very small sample volumes. A volume of
50 microliters is suﬃcient to obtain reliable results. In all
patients on mechanical ventilation with a heat and moisture
exchanger (HME), a small volume of EBC cumulates in the
expiratory tubing of the ventilatory circuit: swivel-derived
exhaled breath condensate (SEBC).
The hypothesis of this study was that it was feasible to
detect cytokines and chemokines in SEBC obtained from
mechanically ventilated ICU patients. We collected SEBC
material directly from the ventilator circuit and used a multi-
plex immunoassay to detect cytokines and chemokines.
2. Methods
2.1. Study Design and Setting. This prospective observational
pilot study was performed in the ICU of Diakonessenhuis,
Utrecht, the Netherlands. Adult patients on invasive
mechanical ventilation were included in this study. We
excluded patients with purulent or haemorrhagic sputum
that required active humidiﬁcation instead of a heat and
moisture exchanger (HME). The study was approved by the
medical ethical committee (METC) of the Diakonessenhuis
Utrecht. A waiver for informed consent was given due to
the noninvasive nature of the study.
2.2. Study Outcomes. The primary outcome of this feasibility
study was to detect cytokines and chemokines in SEBC
obtained in standard ICU bedside conditions. Secondary
outcomes were to assess the correlation between cytokine
and chemokine concentrations in SEBC and mechanical
ventilation parameters, systemic inﬂammation parameters,
and hemodynamic parameters.
2.3. Data Collection
2.3.1. Swivel-Derived EBC Sample Collection. SEBC sampling
was performed by two researchers (HE and IW) between 8
and 10 a.m. before routine airway care. The tube and the
swivel adapter were disconnected, and droplets in the swivel
adapter were directly aspirated with a 3mL disposable pipet.
The SEBC samples were stored in 2mL containers and
immediately cooled in ice. Within 15 minutes following
collection, the samples were stored at -80°C.
2.3.2. Multiplex Immunoassay. SEBC samples were analysed
with a multiplex immunoassay (Luminex, Austin, TX, R&D
Systems Cytokines) according to manufacturer’s instruction
protocol (R&D Systems). The concentrations of a set of cyto-
kines (IL-1β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12,
IL-13, IL-17, IFN-γ, G-CSF, and TNF-α) and chemokines
(MCP-1 and MIP-1β) were measured.
2.3.3. Patient Data Collection. Demographic and clinical
characteristics of the patients were retrieved from the patient
data management system (PDMS, MetaVision). All patients
were ventilated with a Servo-i mechanical ventilator in either
pressure control or pressure support mode. Airway pressure
levels and fraction of inspired oxygen (FiO2) were adjusted
by the attending physician. The following respiratory vari-
ables were recorded at the moment of SEBC sampling: mode
of ventilation, tidal volume (Vt), positive end-expiratory
pressure (PEEP), peak airway pressure, plateau airway pres-
sure, FiO2, pulmonary dynamic compliance, and PaO2/FiO2
(P/F) ratio. In addition, the mean arterial blood pressure
(MAP), heart rate, urinary output in two hours before sam-
pling, dose of noradrenaline (target MAP > 65mmHg), and
central temperature were recorded. The following laboratory
parameters were assessed at the day of SEBC sampling:
serum lactate, haemoglobin, sodium, potassium, CRP, white
blood cell count (WBC), platelet count, urea, and creatinine.
Arterial blood gas results before the moment of sampling
were recorded as well.
2.4. Statistical Analysis. Descriptive characteristics are shown
as the median and range. Correlation coeﬃcients were calcu-
lated by using Pearson’s correlation coeﬃcients, provided
that at least 10 samples had detectable cytokine or chemokine
concentrations. All statistical analyses were performed in
IBM SPSS Statistics 21. A diﬀerence of p < 0:05 was consid-
ered statistically signiﬁcant.
3. Results
3.1. Patient Characteristics. Twenty-nine SEBC samples were
obtained from 13 patients (median 2 samples, range 1-4).
Patient characteristics are shown in Table 1. None of the
patients was diagnosed with a VAP or ARDS according to
recent deﬁnitions [1, 9]. Seven SEBC samples were taken
during pressure control ventilation and 22 during pressure
support ventilation.
3.2. Feasibility.All cytokines and chemokines were detectable
in SEBC samples except for IL-2 (Table 2). IL-1β, IL-4, IL-8,
and IL-17 were detected in more than 90% of SEBC samples,
but ranges varied greatly. In addition, we found signiﬁcant
correlations between cytokine and chemokine concentrations
(Table 3).
Correlations with mechanical ventilation parameters,
systemic inﬂammation, and hemodynamic parameters are
shown in the supplementary ﬁles (available here). Cytokine
and chemokine concentrations in SEBC samples did not dif-
fer between patients on pressure control or pressure support
ventilation. High Vt (mL/kg PBW) was correlated with IL-10
(r = :391, p < 0:05), IL-12 (r = :392, p < 0:05), and MIP-1β
(r = :397, p < 0:05). High P/F ratio was correlated with IL-8
(r = :427, p < 0:05) and MCP-1 (r = :381, p < 0:05). In addi-
tion, we observed signiﬁcant correlations between high
serum lactate and IL-1β (r = :889, p < 0:01), IL-6 (r = :817,
p < 0:01), IL-8 (r = :742, p < 0:05), MIP-1β (r = :797,
p < 0:01), and TNF-α (r = :790, p < 0:01).
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4. Discussion
In this pilot study, we showed that it is feasible to detect cyto-
kines and chemokines in SEBC samples obtained directly
from the ventilator circuit without the use of a cooling mod-
ule. The cytokines and chemokines in SEBC correlated
signiﬁcantly with each other. We found correlations between
cytokine and chemokine concentrations and mechanical
ventilation parameters, as well as high serum lactate.
Although the small sample size of this study prevents any
deﬁnitive conclusions, the measurement of cytokines and
chemokines in SEBC has the potential to become a noninva-
sive bedside method to detect pulmonary inﬂammation.
In line with a previous research, cytokine and chemokine
concentrations in SEBC samples were low and concentra-
tions varied widely [10–15]. Both the wide variation and
low concentrations are the result of EBC formation in the air-
ways and EBC sample dilution. The exact origin of EBC is
uncertain, but McNeil et al. found that there is a correlation
between ﬂuids extracted from the HME ﬁlter and oedema
ﬂuid aspirated directly from the airways [16]. Therefore,
it is suggested that EBC originates from the airway lining
ﬂuid covering the respiratory tract [8, 17]. Up to 99.9%
of EBC consists of evaporated water, and only a small pro-
portion consists of both volatile and nonvolatile compounds
[3, 18–20]. The nonvolatile compounds, including cytokines
and chemokines, are shed from the airway surfaces as
small droplets of airway lining ﬂuid during tidal breathing
[8, 17, 19]. The number of droplets detected in exhaled
breath air varies greatly resulting in variable sample dilution
[17]. Currently, there is no consensus on a method to correct
for sample dilution. It has been suggested to calculate pro-
portions between substances in order to correct for sample
dilution [21, 22]. In our study, we found multiple well-
known correlations between cytokines and chemokines in
SEBC samples. The combination of IL-6 and IL-8 is fre-
quently used in ARDS research [23, 24], whereas IL-13 was
only present in combination with high IL-5 concentrations;
both are T-helper cell 2 cytokines associated with airway
hyperresponsiveness [25].
Mechanical ventilation with high airway pressures and
high tidal volumes is associated with increased mortality in
patients with ARDS [26]. Until now, only Gessner and
Hartmut found a strong correlation between EBC nitrite
levels and tidal volume in an ICU population [27]. In this
study, we found signiﬁcant correlations between high peak
airway pressure and G-CSF and between high tidal volume
(mL/kg PBW) and IL-10, IL-12, and MIP-1β. In contrast,
Fernandez-Bustamante et al. did not ﬁnd a diﬀerence in
EBC cytokines between low tidal volume (6mL/kg) and
intermediate tidal volume (10mL/kg) after one hour of
mechanical ventilation in healthy perioperative patients
[15]. Multiple cytokines were undetectable in their study
despite the use of a multiplex immunoassay. The undetect-
able concentrations could be explained by the small diﬀer-
ence in tidal volumes, as a tidal volume of 10mL/kg does
not increase the mortality rate in ICU patients without ARDS
[28]. In addition, in healthy perioperative patients, the endo-
thelial barrier function is preserved and might not have been
aﬀected by one hour of mechanical ventilation.
Despite the small sample size, we found strong corre-
lations between high serum lactate and IL-1β, IL-6, IL-8,
G-CSF, MIP-1β, and TNF-α concentrations in SEBC. Previ-
ously, we have suggested that ATP levels in EBC samples did
not accurately reﬂect serum lactate in healthy patients [29].
Table 1: Patient characteristics of 13 mechanically ventilated
patients.
Male (n, %) 7 (54)
Age 69 (37-77)
Reason for admission, n (%)
(i) Complications of previous abdominal or
vascular surgery
4 (30%)
(ii) Cardiac failure 2 (15%)
(iii) Pneumonia (without severe sepsis or shock) 2 (15%)
(iv) Severe sepsis/septic shock 2 (15%)
(v) Other 3 (23%)
APACHE II score 25 (14-39)
Peak airway pressure (cmH2O) 18 (10-36)
Plateau airway pressure (cmH2O) 12.5 (6-24)
Positive end-expiratory pressure (cmH2O) 8 (5-18)
Tidal volume (mL/kg predicted body weight) 7.2 (5.1-11.0)
Fraction of inspired oxygen (%) 35 (25-70)
PaO2/FiO2 ratio (mmHg) 252 (95-364)
Respiratory system compliance (mL/cmH2O) 48 (8-208)
Data are presented as the median and range unless stated otherwise.









IL-1β 26 (93)∗ 0.12 0.00-13.71
IL-2 0 — —
IL-4 26 (90) 0.26 0.00-0.84
IL-5 3 (10) 0.00 0.00-0.60
IL-6 15 (52) 0.00 0.00-131.80
IL-7 2 (7) 0.00 0.00-9.37
IL-8 27 (96)∗ 2.55 0.00-6448.00
IL-10 24 (86)∗ 0.03 0.00-61.14
IL-12 21 (72) 0.04 0.00-7.36
IL-13 1 (3) 0.00 0.00-1.52
IL-17 26 (90) 1.30 0.00-4.75
G-CSF 2 (7)∗ 0.00 0.00-17.90
IFN-γ 12 (41) 0.00 0.00-96.13
MCP-1 25 (86) 0.86 0.00-711.76
MIP-1β 16 (55) 0.22 0.00-656.92
TNF-α 12 (41) 0.00 0.00-15.51
∗One result not available in immunoassay (n = 28). IL: interleukin; G-CSF:
granulocyte colony-stimulating factor; IFN: interferon; MCP: monocyte
chemoattractant protein; MIP: macrophage inﬂammatory protein; TNF:
tumour necrosis factor.
3Disease Markers
In critically ill patients, the endothelial barrier function is
impaired, which could be an explanation for the strong cor-
relations found between serum lactate and cytokines and
chemokines in SEBC. Parameters associated with an active
infection, such as CRP and white blood cell count, were not
signiﬁcantly correlated with cytokines and chemokines in
SEBC samples. Therefore, we hypothesize that the raised
concentrations of cytokines and chemokines in SEBC sam-
ples are the result of endothelial barrier dysfunction, and
not of infection.
This pilot study has several limitations. First, this study
was designed as a pilot study with a primary aim to establish
the feasibility of detection of cytokines and chemokines in
SEBC samples collected without a cooling module. There-
fore, the sample size was small and the correlations found
are likely to overestimate or underestimate the true eﬀect.
Second, we did not collect matching plasma samples to mea-
sure cytokines and chemokines to correlate with the SEBC
samples. Third, no SEBC dilution factors were calculated.
We decided to present the raw data as there is no consensus
on the calculation of EBC sample dilution [3, 5]. IL-8 could
be used as a denominator, as this cytokine is detectable in
96% of measured samples. Lastly, we did not compare SEBC
with EBC collected by a cooling module, as there is no gold
standard for EBC collection.
Despite these limitations, this pilot study demonstrated
that cytokines and chemokines can be detected in SEBC.
The only prerequisite is the use of a HME, as active humidiﬁ-
cation potentially results in sample dilution [5]. This simple
SEBC collection method provides a unique opportunity to
collect EBC samples in large prospective ICU cohorts, in order
to determine whether cytokines and chemokines are corre-
lated with mechanical ventilation parameters and systemic
parameters or even predict the development ofARDS orVAP.
5. Conclusion
This pilot study showed that it is feasible to detect cytokines
and chemokines in SEBC samples obtained directly from the
ventilator circuit without the use of a cooling module.
Although the sample size was small, correlations were found
between cytokines and chemokines in SEBC, as well as
mechanical ventilation parameters and high serum lactate
concentrations. This simple SEBC collectionmethod provides
the opportunity to collect EBC samples in large prospective
ICU cohorts.
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Table 3: Correlation coeﬃcients between cytokines and chemokines in SEBC.
IL-1β IL-4 IL-6 IL-8 IL-10 IL-12 IL-17 IFN-γ MCP-1 MIP-1β TNF -α
IL-1β —
IL-4 .021 —
IL-6 .212 -.063 —
IL-8 .097 -.156 .963∗∗ —
IL-10 -.089 -.122 -.045 -.048 —
IL-12 -.071 -.100 -.027 -.040 .991∗∗ —
IL-17 .076 .115 -.164 -.212 .257 -.212 —
IFN-γ -.103 .056 -.062 -.095 .823∗∗ .822∗∗ .063 —
MCP-1 .060 -.128 .967∗∗ .990∗∗ .045 .058 -.220 -.001 —
MIP-1β -.082 -.116 -.006 -.009 .999∗∗ .992∗∗ -.278 .821∗∗ .084 —
TNF-α .352 .336 .365 .213 -.02 .024 .282 .411∗ .228 .017 —
A positive value indicates a positive correlation, whereas a negative value indicates a negative correlation; ∗p < 0:05 and ∗∗p < 0:01. IL: interleukin;
IFN: interferon; MCP: monocyte chemoattractant protein; MIP: macrophage inﬂammatory protein; TNF: tumour necrosis factor.
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